What B59 covers · when clinicians use it
ICD-10 code B59 identifies Pneumocystosis in the U.S. ICD-10-CM clinical and billing record set. It sits within the Certain Infectious and Parasitic Diseases chapter (A00–B99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply B59 when an encounter's findings match the Pneumocystosis description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify B59 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for B59 and is a coding reference, not clinical, diagnostic, or billing advice.
B59 refers to Pneumocystosis, a parasitic or protozoal infection that can range from self-limiting to life-threatening. These infections are often vector-borne or zoonotic and may affect multiple organ systems. Accurate ICD10 coding ensures proper diagnosis, treatment tracking, and public health reporting, especially in endemic areas.
Symptoms
- Fever – Often periodic in malaria and persistent in other protozoal diseases
- Chills and sweating – Common in malaria cycles
- Enlarged spleen or liver – Seen in chronic parasitic infections
- Muscle pain and fatigue – General systemic symptoms
- Neurological symptoms – Possible in cerebral malaria or trypanosomiasis
- Skin ulcers – Seen in cutaneous leishmaniasis
- Respiratory distress – Especially in pneumocystosis and toxoplasmosis
Diagnosis
Diagnosis of Pneumocystosis is based on clinical signs and confirmed by laboratory tests. These include blood smears (malaria), serology, PCR, antigen detection, or biopsy of affected tissue. Imaging may be used in complications involving the brain, lungs, or heart. Accurate diagnosis is crucial for prompt treatment and disease containment.
ICD10 Code Usage
ICD10 code B59 helps clinicians, coders, and public health officials classify and track protozoal infections. It supports insurance billing, epidemiological surveillance, and international reporting of tropical diseases. In clinical settings, it enables standardized care and helps allocate appropriate treatments and isolation protocols.
Related Codes
- B50 – Plasmodium falciparum malaria
- B51 – Plasmodium vivax malaria
- B52 – Plasmodium malariae malaria
- B53 – Other specified malaria
- B54 – Unspecified malaria
- B55 – Leishmaniasis
- B56 – African trypanosomiasis
- B57 – Chagas' disease
- B58 – Toxoplasmosis
- B60 – Other protozoal diseases, not elsewhere classified
- B64 – Unspecified protozoal disease
FAQs
Q1: What is ICD10 code B59?
A: This ICD10 code refers to Pneumocystosis, used to classify protozoal and parasitic diseases in healthcare documentation.
Q2: Are these diseases preventable?
A: Many are preventable through vector control, sanitation, and prophylactic medications or vaccines (in the case of malaria).
Q3: Who is at risk?
A: People in endemic regions, travelers, and immunocompromised individuals are most vulnerable.
Q4: Are these conditions curable?
A: Many are treatable with antiparasitic medications if diagnosed early.
Q5: Can these diseases become chronic?
A: Yes, diseases like Chagas' and leishmaniasis can have chronic stages affecting organs long term.
Conclusion
ICD10 code B59 plays a crucial role in documenting and managing Pneumocystosis. Proper coding aids in treatment planning, outbreak response, and global disease tracking. It is essential for improving patient care, guiding public health initiatives, and ensuring accurate healthcare billing and records.